文献速递重症综合管理与镇静镇痛

谵妄亚型对重症内科与外科患者预后的意义:一项前瞻性多中心研究的二次分析

Prognostic significance of delirium subtypes in critically ill medical and surgical patients: a secondary analysis of a prospective multicenter study.
PubMed 文献 · J Intensive Care · 2022-12-20
一句话结论混合型谵妄患者院内死亡风险约为无谵妄患者的3倍(OR 3.09),而活动减退型未达统计学显著(OR 1.34),提示临床应区分谵妄亚型。

本研究为2012至2015年在荷兰开展的前瞻性多中心研究的二次分析,纳入1564例成人内科或外科ICU患者,排除神经系统入院诊断、持续昏迷或ICU再入院者。采用CAM-ICU或ICDSC评估谵妄,用RASS分类亚型。381例(24.4%)发生谵妄,其中活动减退型52.5%、混合型39.1%、活动亢进型7.3%。经病例组合调整后,混合型谵妄患者院内死亡率高于无谵妄患者(OR 3.09,95%CI 1.79-5.33,p=0.001),活动减退型未达统计学显著(OR 1.34,95%CI 0.71-2.55,p=0.37);ICU死亡率结果相似。作者认为临床实践与未来研究应区分谵妄亚型。

要点

  • 混合型谵妄患者院内死亡率高于无谵妄患者(OR 3.09,95%CI 1.79-5.33,p=0.001),活动减退型未达统计学显著(OR 1.34,95%CI 0.71-2.55,p=0.37)。
  • ICU死亡率结果与院内死亡率相似。
  • 与无谵妄患者相比,活动减退型与混合型均延长ICU停留时间、增加昏迷、提高机械通气频率与时长,并更多使用抗精神病药、镇静剂、苯二氮䓬类和阿片类。
  • 除昏迷和苯二氮䓬类使用外,最不利的结局见于混合型谵妄患者。
  • 谵妄总发生率24.4%(381/1564),活动减退型占52.5%、混合型39.1%、活动亢进型7.3%。

适用人群与场景

  • 成人(≥18岁)收入内科或外科ICU的患者。
  • 排除标准:神经系统入院诊断、持续昏迷或ICU再入院。

诊断标准与关键阈值

  • 谵妄评估采用ICU意识模糊评估法(CAM-ICU)或重症监护谵妄筛查量表(ICDSC)。
  • 谵妄亚型(活动减退型、活动亢进型或混合型)采用里士满躁动-镇静量表(RASS)分类。

研究设计与关键结果

  • 研究类型:前瞻性多中心研究的二次分析,旨在实施谵妄导向措施,2012至2015年在荷兰开展,注册号ClinicalTrials.gov NCT01952899。
  • 共纳入1564例患者,381例(24.4%)发生谵妄,其中活动减退型52.5%、混合型39.1%、活动亢进型7.3%。
  • 主要终点院内死亡率:经病例组合调整后,混合型谵妄患者高于无谵妄患者(OR 3.09,95%CI 1.79-5.33,p=0.001),活动减退型未达统计学显著(OR 1.34,95%CI 0.71-2.55,p=0.37)。
  • ICU死亡率结果与院内死亡率相似。
  • 与无谵妄患者相比,活动减退型与混合型均延长ICU停留时间、增加昏迷、提高机械通气频率与时长,并更多使用抗精神病药、镇静剂、苯二氮䓬类和阿片类。
  • 除昏迷和苯二氮䓬类使用外,最不利的结局见于混合型谵妄患者。

证据类型、等级与局限

  • 证据类型:前瞻性多中心研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,这些差异支持在临床实践和未来研究中区分谵妄亚型。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The prognostic implication of delirium subtypes in critically ill medical and surgical patients is scarcely investigated. The objective was to determine how delirium subtypes are associated with hospital mortality and other clinical outcomes.

METHODS: We performed a secondary analysis on data from a prospective multicenter study aimed at implementation of delirium-oriented measures, conducted between 2012 and 2015 in The Netherlands. We included adults (≥ 18 years) admitted to the medical or surgical intensive care unit (ICU). Exclusion criteria were neurological admission diagnosis, persistent coma or ICU readmissions. Delirium was assessed using the Confusion Assessment Method-ICU or Intensive Care Delirium Screening Checklist, and delirium subtypes (hypoactive, hyperactive, or mixed) were classified using the Richmond Agitation-Sedation Scale. The main outcome was hospital mortality. Secondary outcomes were ICU mortality, ICU length of stay, coma, mechanical ventilation, and use of antipsychotics, sedatives, benzodiazepines and opioids.

RESULTS: Delirium occurred in 381 (24.4%) of 1564 patients (52.5% hypoactive, 39.1% mixed, 7.3% hyperactive). After case-mix adjustment, patients with mixed delirium had higher hospital mortality than non-delirious patients (OR 3.09, 95%CI 1.79-5.33, p = 0.001), whereas hypoactive patients did not (OR 1.34, 95%CI 0.71-2.55, p = 0.37). Similar results were found for ICU mortality. Compared to non-delirious patients, both subtypes had longer ICU stay, more coma, increased mechanical ventilation frequency and duration, and received more antipsychotics, sedatives, benzodiazepines and opioids. Except for coma and benzodiazepine use, the most unfavourable outcomes were observed in patients with mixed delirium.

CONCLUSIONS: Patients with mixed delirium had the most unfavourable outcomes, including higher mortality, compared with no delirium. These differences argue for distinguishing delirium subtypes in clinical practice and future research. Trial registration ClinicalTrials.gov NCT01952899.

来源:J Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Smit L, Wiegers EJA, Trogrlic Z, et al. Prognostic significance of delirium subtypes in critically ill medical and surgical patients: a secondary analysis of a prospective multicenter study. J Intensive Care. 2022. PMID: 36539913. doi:10.1186/s40560-022-00644-1

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。